- Home
- NTZ vs LTRN Comparison
NTZ vs LTRN Comparison
Compare NTZ & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- LTRN
- Stock Information
- Founded
- NTZ 1959
- LTRN 2013
- Country
- NTZ Italy
- LTRN United States
- Employees
- NTZ N/A
- LTRN N/A
- Industry
- NTZ Home Furnishings
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- LTRN Health Care
- Exchange
- NTZ Nasdaq
- LTRN Nasdaq
- Market Cap
- NTZ 41.6M
- LTRN 36.0M
- IPO Year
- NTZ 1993
- LTRN 2020
- Fundamental
- Price
- NTZ $3.25
- LTRN $3.74
- Analyst Decision
- NTZ
- LTRN Strong Buy
- Analyst Count
- NTZ 0
- LTRN 1
- Target Price
- NTZ N/A
- LTRN $25.00
- AVG Volume (30 Days)
- NTZ 1.8K
- LTRN 281.3K
- Earning Date
- NTZ 07-02-2025
- LTRN 08-07-2025
- Dividend Yield
- NTZ N/A
- LTRN N/A
- EPS Growth
- NTZ N/A
- LTRN N/A
- EPS
- NTZ N/A
- LTRN N/A
- Revenue
- NTZ $337,653,480.00
- LTRN N/A
- Revenue This Year
- NTZ N/A
- LTRN N/A
- Revenue Next Year
- NTZ N/A
- LTRN N/A
- P/E Ratio
- NTZ N/A
- LTRN N/A
- Revenue Growth
- NTZ N/A
- LTRN N/A
- 52 Week Low
- NTZ $3.04
- LTRN $2.55
- 52 Week High
- NTZ $6.27
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- NTZ 31.63
- LTRN 63.62
- Support Level
- NTZ $3.25
- LTRN $3.21
- Resistance Level
- NTZ $3.32
- LTRN $3.75
- Average True Range (ATR)
- NTZ 0.05
- LTRN 0.24
- MACD
- NTZ -0.06
- LTRN 0.07
- Stochastic Oscillator
- NTZ 0.00
- LTRN 98.65
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.